Cargando…

Liver metabolomics reveals potential mechanism of Jieduan-Niwan formula against acute-on-chronic liver failure (ACLF) by improving mitochondrial damage and TCA cycle

BACKGROUND: Acute-on-chronic liver failure (ACLF) is a refractory disease with high mortality, which is characterized by a pathophysiological process of inflammation-related dysfunction of energy metabolism. Jieduan-Niwan formula (JDNWF) is a eutherapeutic Chinese medicine formula for ACLF. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Jiajun, Wei, Xiaoyi, Hou, Weixin, Wang, Hanjing, Ma, Ruimin, Gao, Yanbin, Du, Yuqiong, Zhang, Qiuyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691013/ https://www.ncbi.nlm.nih.gov/pubmed/38037150 http://dx.doi.org/10.1186/s13020-023-00858-x

Ejemplares similares

Network Pharmacology Approach to Explore the Potential Mechanisms of Jieduan-Niwan Formula Treating Acute-on-Chronic Liver Failure
por: Liang, Jiajun, et al.
Publicado: (2020)

The Jieduan-Niwan (JDNW) Formula Ameliorates Hepatocyte Apoptosis: A Study of the Inhibition of E2F1-Mediated Apoptosis Signaling Pathways in Acute-on-Chronic Liver Failure (ACLF) Using Rats
por: Hou, Weixin, et al.
Publicado: (2021)

Jieduan–Niwan Formula Ameliorates Oxidative Stress and Apoptosis in Acute-on-Chronic Liver Failure by Suppressing HMGB1/TLR-4/NF-κB Signaling Pathway: A Study In Vivo and In Vitro
por: Fang, Peng, et al.
Publicado: (2022)

Jieduan-Niwan Formula Reduces Liver Apoptosis in a Rat Model of Acute-on-Chronic Liver Failure by Regulating the E2F1-Mediated Intrinsic Apoptosis Pathway
por: Yang, Wenlong, et al.
Publicado: (2019)

Bioinformatics analyses of potential ACLF biological mechanisms and identification of immune-related hub genes and vital miRNAs
por: Liang, Jiajun, et al.
Publicado: (2022)

HMGB1-Induced Hepatocyte Pyroptosis Expanding Inflammatory Responses Contributes to the Pathogenesis of Acute-on-Chronic Liver Failure (ACLF)
por: Hou, Weixin, et al.
Publicado: (2021)

Quercetin Reduces Oxidative Stress and Apoptosis by Inhibiting HMGB1 and Its Translocation, Thereby Alleviating Liver Injury in ACLF Rats
por: Fang, Peng, et al.
Publicado: (2021)

Prognostic Value of Acute-On-Chronic Liver Failure (ACLF) Score in Critically Ill Patients with Cirrhosis and ACLF
por: Lin, Xinran, et al.
Publicado: (2020)

Comparing CLIF-C ACLF, CLIF-C ACLF(lactate), and CLIF-C ACLF-D Prognostic Scores in Acute-on-Chronic Liver Failure Patients by a Single-Center ICU Experience
por: Kuo, Chao-Cheng, et al.
Publicado: (2021)

A Modified MELD Model for Chinese Pre-ACLF and ACLF Patients and It Reveals Poor Prognosis in Pre-ACLF Patients
por: Xia, Qi, et al.
Publicado: (2013)

The Role of TCA Cycle Anaplerosis in Ketosis and Fatty Liver in Periparturient Dairy Cows
por: White, Heather M.
Publicado: (2015)

Changes in TCA cycle and TCA cycle-related metabolites in plasma upon citric acid administration in rats
por: Hara, Yurie, et al.
Publicado: (2021)

Acute-on-chronic liver failure (ACLF) precipitated by severe alcoholic hepatitis: another collateral damage of the COVID-19 pandemic?
por: Görgülü, Esra, et al.
Publicado: (2022)

Multiple organ involvement and ICU considerations for the care of acute liver failure (ALF) and acute on chronic liver failure (ACLF) in children
por: Mataya, Leslie A., et al.
Publicado: (2021)

Rotational thrombelastometry (ROTEM) improves hemostasis assessment compared to conventional coagulation test in ACLF and Non-ACLF patients
por: Seeßle, Jessica, et al.
Publicado: (2020)

Influence of Advanced Organ Support (ADVOS) on Cytokine Levels in Patients with Acute-on-Chronic Liver Failure (ACLF)
por: Kaps, Leonard, et al.
Publicado: (2022)

Effectiveness and Safety of Baidu Jieduan Granules for COVID-19: A Retrospective Observational Multicenter Study
por: Xu, Xiang-ru, et al.
Publicado: (2022)

Fumarase: From the TCA Cycle to DNA Damage Response and Tumor Suppression
por: Leshets, Michael, et al.
Publicado: (2018)

Rescue of TCA Cycle Dysfunction for Cancer Therapy
por: Marquez, Jubert, et al.
Publicado: (2019)

Identification and characterization of the TCA cycle genes in maize
por: Liu, Yongming, et al.
Publicado: (2019)

Comparison of CLIF-C ACLF Score and MELD Score in Predicting ICU Mortality in Patients with Acute-On-Chronic Liver Failure
por: Ramzan, Moazma, et al.
Publicado: (2020)

Mitochondrial metabolism in TCA cycle mutant cancer cells
por: Sullivan, Lucas B, et al.
Publicado: (2014)

The emerging role and targetability of the TCA cycle in cancer metabolism
por: Anderson, Nicole M., et al.
Publicado: (2017)

Mitochondrial TCA cycle metabolites control physiology and disease
por: Martínez-Reyes, Inmaculada, et al.
Publicado: (2020)

Operation of a TCA cycle subnetwork in the mammalian nucleus
por: Kafkia, Eleni, et al.
Publicado: (2022)

Connection between HPS and ACLF: a solution of chaos?
por: Maruyama, Hitoshi, et al.
Publicado: (2021)

Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Qingdu Decoction against Chronic Liver Injury
por: Ma, Chongyang, et al.
Publicado: (2021)

Metabolomics and Gene Expression Analysis Reveal Down-regulation of the Citric Acid (TCA) Cycle in Non-diabetic CKD Patients
por: Hallan, Stein, et al.
Publicado: (2017)

A Fresh Take on the “TCA” Cycle: TETs, Citrate, and Asthma
por: Huang, Steven K.
Publicado: (2020)

MITF controls the TCA cycle to modulate the melanoma hypoxia response
por: Louphrasitthiphol, Pakavarin, et al.
Publicado: (2019)

TCA Cycle Rewiring as Emerging Metabolic Signature of Hepatocellular Carcinoma
por: Todisco, Simona, et al.
Publicado: (2019)

Tricarboxylic Acid (TCA) Cycle Intermediates: Regulators of Immune Responses
por: Choi, Inseok, et al.
Publicado: (2021)

Emerging Role of TCA Cycle-Related Enzymes in Human Diseases
por: Kang, Woojin, et al.
Publicado: (2021)

A new model for identification of HBV-related pre-ACLF
por: Jalan, Rajiv, et al.
Publicado: (2022)

Network Pharmacology-Based Analysis on the Potential Biological Mechanisms of Sinisan Against Non-Alcoholic Fatty Liver Disease
por: Wei, Xiaoyi, et al.
Publicado: (2021)

Phenotypes and clinical significance of circulating CD4(+)CD25(+) regulatory T cells (Tregs) in patients with acute-on-chronic liver failure (ACLF)
por: Yang, Jiezuan, et al.
Publicado: (2012)

Validation of CLIF-C ACLF score to define a threshold for futility of intensive care support for patients with acute-on-chronic liver failure
por: Engelmann, Cornelius, et al.
Publicado: (2018)

Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive care
por: Kaps, L., et al.
Publicado: (2021)

A case series of drug induced liver injury leading to ACLF after complementary & alternative medicine over-use for COVID-19
por: Jeji, Pukhraj Singh, et al.
Publicado: (2022)

Lower level of IL‐28A as a predictive index of the artificial liver support system in effective treatment of patients with HBV‐ACLF
por: Huang, Yandi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nlg6u0f40b2qhqih8thiq2edta